Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Short-Term Investments Investment, Policy [Policy Text Block] Intangible Asset Amortization Intangible Asset Amortization [Member] Intangible Asset Amortization Rebecca Chambers [Member] Rebecca Chambers Award Timing Predetermined Award Timing Predetermined [Flag] Remainder of 2025 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Shares in acquisition consideration (in shares) Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Net cash outflows from deconsolidation Proceeds from Divestiture of Businesses, Net of Cash Divested Accounts payable Increase (Decrease) in Accounts Payable Schedule of Major Classes of Asset and Liabilities Deconsolidated and Loss on Deconsolidation Disposal Groups, Including Discontinued Operations [Table Text Block] Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Basic (in USD per share) Basic EPS (in USD per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance US Treasury Bill Securities US Treasury Bill Securities [Member] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Discount rate Measurement Input, Discount Rate [Member] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Supplies Other Inventory, Supplies, Gross Measurement Input Type [Domain] Measurement Input Type [Domain] Total assets deconsolidated Disposal Group, Including Discontinued Operation, Assets Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk Concentration Risk, Percentage Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Shares of common stock subject to outstanding options Options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Other general and administrative expenses Other General and Administrative Expense Cash paid for tax Income Taxes Paid Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Impairment of assets Impairment loss Non-cash impairment charge Asset Impairment Charges Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Insider Trading Policies and Procedures [Line Items] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Phil Febbo Trading Arrangement, Vested Restricted Stock Units (RSUs) [Member] Phil Febbo Trading Arrangement, Vested Restricted Stock Units (RSUs) Current assets: Assets, Current [Abstract] Total liabilities and stockholders’ equity Liabilities and Equity Issuance of common stock and options for acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] Intangible asset amortization - cost of revenue Cost, Amortization General and administrative: General and Administrative Expense [Member] Weighted Average Remaining Amortization Period (Years) Finite-Lived Intangible Asset, Useful Life Total Finite-Lived Intangible Assets, Net Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable, Current Present value of future lease payments Operating Lease, Liability Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Business Combination Business Combination [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other liabilities Other Liabilities, Noncurrent Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Net comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Measurement Input Type [Axis] Measurement Input Type [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Name Measure Name Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Class of Stock [Line Items] Class of Stock [Line Items] Deferred tax liabilities Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Annie McGuire [Member] Annie McGuire Award Timing Method Award Timing Method [Text Block] Veracyte SAS Veracyte SAS [Member] Veracyte SAS Award Type [Axis] Award Type [Axis] Current liabilities: Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract] Total assets Assets Direct expense Direct Operating Expenses Direct Operating Expenses Investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year One Trading Symbol Trading Symbol 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Schedule of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] License fees and royalties Cost Of Revenue, License Fees And Royalties Cost Of Revenue, License Fees And Royalties Entity Address, City or Town Entity Address, City or Town Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Concentration Risk Type [Axis] Concentration Risk Type [Axis] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Restricted stock units Restricted Stock Units (RSUs) [Member] Annie McGuire Trading Arrangement, Vested Restricted Stock Units [Member] Annie McGuire Trading Arrangement, Vested Restricted Stock Units Other selling and marketing expenses Other Selling and Marketing Expense Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Acquisition consideration Business Combination, Consideration Transferred 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Four Entity Emerging Growth Company Entity Emerging Growth Company Short term investments fair value Debt Securities, Held-to-Maturity, Fair Value Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Stock options and restricted stock units issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Restricted cash Restricted Cash and Cash Equivalent Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Laboratory supplies and reagents expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Allocation of facilities and IT expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses PEO PEO [Member] Schedule of Revenue Disaggregation of Revenue [Table Text Block] Non-cash loss on deconsolidation of subsidiary Non-Cash Deconsolidation, Gain (Loss), Amount Non-Cash Deconsolidation, Gain (Loss), Amount Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Current assets: Disposal Group, Including Discontinued Operation, Assets, Current [Abstract] Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax (benefit) provision Income tax expense (benefit) Income Tax Expense (Benefit) Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Common stock equivalent shares excluded from the dilutive calculation due to antidilutive effect: Antidilutive Securities Excluded From Computation Of Earnings Per Share [Abstract] Antidilutive Securities Excluded From Computation Of Earnings Per Share Customer Concentration Risk Customer Concentration Risk [Member] Right-of-use assets, operating leases Disposal Group, Including Discontinued Operation, Operating Lease, Right-Of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease, Right-Of-Use Asset Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Business Combination [Table] Business Combination [Table] Total cost of revenue Cost Of Revenue, Including Amortization Cost Of Revenue, Including Amortization Organization, Consolidation and Presentation of Financial Statements [Abstract] C2i developed technology C2i Developed Technology [Member] C2i Developed Technology Other Income and Expenses [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised City Area Code City Area Code Acquisition of C2i, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Commitments and Contingencies Disclosure [Abstract] General and administrative Total general and administrative General and Administrative Expense Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net liabilities deconsolidated Net liabilities deconsolidated Disposal Group, Including Discontinued Operation, Net Assets (Liabilities) Disposal Group, Including Discontinued Operation, Net Assets (Liabilities) Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share C2i C2i Genomics, Inc. [Member] C2i Genomics, Inc. Goodwill Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Money Market Funds Money Market Funds [Member] 2025 remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Equity Components [Axis] Equity Components [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Product revenue Product [Member] Number of reporting segments Number of Reportable Segments Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Change in currency translation adjustments Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Entity Address, State or Province Entity Address, State or Province Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Total current liabilities Liabilities, Current Sample collection expense Cost Of Revenue, Sample Collection Expense Cost Of Revenue, Sample Collection Expense Increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Individual: Individual [Axis] Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Research and development: Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Medicare Medicare [Member] Represents Medicare. Operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Equity [Abstract] Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Segment Segment Reporting Disclosure [Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Karin Eastham [Member] Karin Eastham Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability Weighted Average Weighted Average [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Intangible asset amortization - operating expenses Amortization of Intangible Assets Depreciation and amortization Depreciation, Depletion and Amortization Other assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Inventory Inventory, Finished Goods, Gross Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Current portion of deferred revenue Contract with Customer, Liability, Current Segments [Axis] Segments [Axis] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Rebecca Chambers Trading Arrangement, Vested Restricted Stock Units (RSUs) [Member] Rebecca Chambers Trading Arrangement, Vested Restricted Stock Units (RSUs) Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Phil Febbo Trading Arrangement, Common Stock [Member] Phil Febbo Trading Arrangement, Common Stock Current portion of acquisition-related contingent consideration Business Combination, Contingent Consideration, Liability, Current Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Assets Assets [Abstract] C2i Inc C2i Inc [Member] C2i Inc Underlying Security Market Price Change Underlying Security Market Price Change, Percent 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Three Cash and cash equivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Fair Value Measurements Fair Value Disclosures [Text Block] Business Combination [Line Items] Business Combination [Line Items] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Stockholders’ equity: Equity, Attributable to Parent [Abstract] Annie McGuire Trading Arrangement, Common Stock [Member] Annie McGuire Trading Arrangement, Common Stock Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Total research and development Research and Development Expense Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Balance Sheet Related Disclosures [Abstract] Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Property, plant and equipment, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Other assets Increase (Decrease) in Other Noncurrent Assets Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Total liabilities deconsolidated Disposal Group, Including Discontinued Operation, Liabilities Compensation expense Labor and Related Expense Contingent consideration expense (reversal of expense) Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Dilutive potential common shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Rebecca Chambers Trading Arrangement, Common Stock [Member] Rebecca Chambers Trading Arrangement, Common Stock Total operating expenses Costs and Expenses Document Quarterly Report Document Quarterly Report Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two Number of operating segments Number of Operating Segments Amortization of discount on short-term investments Accretion (Amortization) of Discounts and Premiums, Investments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Accounts Receivable Accounts Receivable [Member] Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] 2026 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Net loss on deconsolidation Loss on deconsolidation of subsidiary Deconsolidation, Gain (Loss), Amount Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Statement of Comprehensive Income [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Allocation of facilities and IT expenses Operating Expenses, Allocation Of Facilities And Information Technology Expenses Operating Expenses, Allocation Of Facilities And IT Expenses Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Number of patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Value of shares in acquisition consideration Business Combination, Consideration Transferred, Equity Interest Other Testing Revenue Testing, Other [Member] Testing, Other MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Shares used to compute earnings per common share: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Employee stock purchase plan Common stock available for the Employee Stock Purchase Plan Employee Stock [Member] Revenue: Revenues [Abstract] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Selling and marketing Total selling and marketing Selling and Marketing Expense Financial Instruments [Domain] Financial Instruments [Domain] Segments [Domain] Segments [Domain] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Supplies and inventory Increase (Decrease) in Inventories Supplies and inventory Total supplies and inventory Inventory, Net Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Minimum Minimum [Member] Deposits Deposits for leases Security Deposit Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Cost of revenue: Cost of Revenue [Abstract] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Company Selected Measure Name Company Selected Measure Name Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Numerator for diluted EPS — net income Net Income (Loss) Available to Common Stockholders, Diluted All Executive Categories All Executive Categories [Member] Common stock, $0.001 par value; 125,000,000 shares authorized, 79,034,078 and 77,772,678 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively Common Stock, Value, Issued Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Diluted (in shares) Denominator for diluted EPS — adjusted weighted average shares and assumed conversions (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Business Combination [Axis] Business Combination [Axis] Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Entity Small Business Entity Small Business Selling and marketing: Selling and Marketing Expense [Member] Equity interest acquired Business Combination, Voting Equity Interest Acquired, Percentage Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Release of accumulated translation adjustment Release of accumulated translation adjustment Release of accumulated translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Cash payment of contingent consideration for acquisition Payment for Contingent Consideration Liability, Financing Activities Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Components of Other Income Other Nonoperating Income and Expense [Text Block] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Shares of common stock subject to outstanding options Employee And Non-Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Document Type Document Type Net Income (Loss) Per Common Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Product and Service [Axis] Product and Service [Axis] Revenue Revenue from Contract with Customer Benchmark [Member] Total revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Decipher product technology Decipher Product Technology [Member] Decipher BioSciences Product Technology Deferred income taxes Other Noncash Deferred Income Tax Expense (Benefit) Other Noncash Deferred Income Tax Expense (Benefit) Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Accrued Liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current Disposal Group Classification [Axis] Disposal Group Classification [Axis] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Disposal Group Name [Axis] Disposal Group Name [Axis] Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Numerator for basic EPS — net income Net Income (Loss) Available to Common Stockholders, Basic Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Other comprehensive income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities: Liabilities, Current [Abstract] Intangible asset amortization - operating expenses Intangible asset amortization - operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Prosigna product technology Prosigna Product Technology [Member] Prosigna Product Technology Effect of foreign currency on operations Gain (Loss), Foreign Currency Transaction, before Tax Diluted (in USD per share) Diluted EPS (in USD per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings per share: Earnings Per Share [Abstract] Gross profit Gross Profit Phil Febbo [Member] Phil Febbo Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Two Award Timing Disclosures [Line Items] Total current assets Disposal Group, Including Discontinued Operation, Assets, Current Schedule of Supplies and Inventory Schedule of Inventory, Current [Table Text Block] Accrued compensation expenses Employee-related Liabilities, Current Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Other research and development expenses Other Research and Development Expense Stockholders' Equity Equity [Text Block] Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Net income Net income Net income Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Accrued other Other Accrued Liabilities, Current Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Maximum contingent consideration to be paid Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Entity Current Reporting Status Entity Current Reporting Status Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Income from operations Operating Income (Loss) Accumulated deficit Retained Earnings (Accumulated Deficit) Decipher trade names Decipher Trade Names [Member] Decipher Trade Names Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Other cost Other Cost of Operating Revenue Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Total current liabilities Disposal Group, Including Discontinued Operation, Liabilities, Current Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Other income (loss), net  Total Other income, net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] NanoString NanoString [Member] Represents NanoString. Adjustments to reconcile net income to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Deferred revenue Contract with Customer, Liability Jens Holstein [Member] Jens Holstein Testing revenue Testing [Member] Represents testing. Issuance of common stock and options for acquisition Stock Issued During Period, Value, Acquisitions Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Anti-dilutive potential common shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Termination Date Trading Arrangement Termination Date Net cash (used in) provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Discount rate Operating Lease, Weighted Average Discount Rate, Percent Basic (in shares) Denominator for basic EPS — weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic Product costs Cost of Product and Service Sold Disposal Group Classification [Domain] Disposal Group Classification [Domain] Schedule of Computation of Basic and Diluted Net Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Restricted cash Restricted Cash and Cash Equivalent, Noncurrent Segment Reporting [Abstract] Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Cost of revenue Cost of revenue Cost of Revenue Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Operating lease expense Operating Lease, Expense Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Effect of potentially dilutive common stock from: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Accounts receivable Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Recording of accounts payable to subsidiary Disposal Group, Including Discontinued Operation, Accounts Payable Recognized Disposal Group, Including Discontinued Operation, Accounts Payable Recognized Use of Estimates Use of Estimates, Policy [Policy Text Block] Compensation expense Cost Of Revenue, Compensation Expense Cost Of Revenue, Compensation Expense Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Operating lease liabilities Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Noncurrent Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Current portion of other liabilities Other Liabilities, Current Other expenses Disposal Group, Including Discontinued Operation, Other Expense Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Supplies and inventory Disposal Group, Including Discontinued Operation, Inventory, Current UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Common Stock Common Stock [Member] Short-term investments Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Reportable Segment Reportable Segment [Member] Reportable Segment Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation